Jubilant Pharmova Limited
NSE: JUBLPHARMA · Healthcare
₹896.65
-6.05 (-0.67%)
Last close · 30 Aug 2026, 2:50 am IST
- Open
- ₹905.30
- Day high
- ₹921.70
- Day low
- ₹892.70
- Volume
- 1.92 L
- Prev close
- ₹902.70
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 500Nifty MidSmallcap 400Nifty Smallcap 250
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 15,290 Cr
- Price
- 965.35
- P/E (TTM)
- 38.46
- P/E (Fwd)
- 19.00
- P/B
- 2.15
- EV/EBITDA
- 13.98
- EV/Revenue
- 2.13
- PEG
- 0.14
- Div Yield
- 0.52%
- 52W High
- 1,248.00
- 52W Low
- 786.05
- Beta
- 0.51
Profitability & income
- Revenue (TTM)
- 8,280 Cr
- Net Income (TTM)
- 398 Cr
- EBITDA
- 1,260 Cr
- Gross Margin
- 68.06%
- Op. Margin
- 9.72%
- Net Margin
- 4.81%
- ROE
- 5.96%
- ROA
- 3.62%
- EPS (TTM)
- 25.10
- EPS (Fwd)
- 50.80
Financial health
- Total Debt
- 3,615 Cr
- Total Cash
- 1,268 Cr
- Debt/Equity
- 50.94
- Current Ratio
- 1.62
- Quick Ratio
- 0.95
- Book Value
- 448.50
- Free Cash Flow
- -568 Cr
- Op. Cash Flow
- 1,227 Cr
Growth
- Revenue Growth
- 18.70%
- Earnings Growth
- -22.40%
- Earnings QoQ
- -22.30%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2,272 Cr | 119 Cr | 349 Cr | 223 Cr | 1,559 Cr | — | 3,615 Cr | 7,093 Cr |
| 2025-12-31 | 2,116 Cr | 56 Cr | 270 Cr | 169 Cr | 1,400 Cr | — | — | — |
| 2025-06-30 | 1,879 Cr | 103 Cr | 302 Cr | 192 Cr | 1,261 Cr | — | — | — |
| 2025-03-31 | 1,916 Cr | 154 Cr | 354 Cr | 250 Cr | 1,290 Cr | — | 2,731 Cr | 6,255 Cr |
| 2024-12-31 | 1,814 Cr | 101 Cr | 277 Cr | 196 Cr | 1,239 Cr | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 8,225 Cr | 399 Cr | 1,266 Cr | 819 Cr | 5,581 Cr | 1,227 Cr | 3,615 Cr | 7,093 Cr |
| 2025-03-31 | 7,192 Cr | 839 Cr | 1,590 Cr | 805 Cr | 4,875 Cr | 1,072 Cr | 2,731 Cr | 6,255 Cr |
| 2024-03-31 | 6,645 Cr | 77 Cr | 809 Cr | 523 Cr | 4,223 Cr | 971 Cr | 3,664 Cr | 5,434 Cr |
| 2023-03-31 | 6,219 Cr | -61 Cr | 750 Cr | 230 Cr | 3,997 Cr | 661 Cr | 3,677 Cr | 5,399 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for JUBLPHARMA?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in